SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-23-000031
Filing Date
2023-11-07
Accepted
2023-11-07 16:16:57
Documents
77
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrtx-20230930.htm   iXBRL 10-Q 1471225
2 EX-31.1 a2023q310-qexhibit311.htm EX-31.1 10733
3 EX-31.2 a2023q310-qexhibit312.htm EX-31.2 10731
4 EX-32.1 a2023q310-qexhibit321.htm EX-32.1 6311
10 GRAPHIC vrtx-20230930_g1.gif GRAPHIC 17719
  Complete submission text file 0000875320-23-000031.txt   7764057

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20230930.xsd EX-101.SCH 41173
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20230930_cal.xml EX-101.CAL 81579
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20230930_def.xml EX-101.DEF 223312
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20230930_lab.xml EX-101.LAB 622878
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20230930_pre.xml EX-101.PRE 421368
71 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20230930_htm.xml XML 1387156
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 231384166
SIC: 2834 Pharmaceutical Preparations